Flavia Matovu Kiweewa
ID: UNCST-2021-R013337
|
Characterizing HIV-1 Transmitted Drug Resistance, Polymorphisms in gag, pol, and env and Susceptibility to Antiretroviral Drugs in Viral Isolates from Participants from Uganda in the CO-US-985-6117 (SIENA), GS-US-412-5624 (PURPOSE 1), GS-US-380-1474 and GS-US-292- 0106 Clinical Studies
REFNo: HS8575ES
The Primary Objectives are to:
i) Characterize transmitted drug resistance in clinical trial participants in Uganda
ii) Characterize naturally occurring polymorphisms in HIV-1 non-B subtypes, including their impact on the development of drug resistance
iii) Determine the susceptibility of viral isolates with drug resistance and/or polymorphisms of interest to antiretroviral drugs
|
Uganda |
2026-09-23 9:13:24 |
2029-09-23 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Martha Wilfahrt
ID: UNCST-2026-R024852
|
Tropical Subjects: Ethnographies of Experimentation
REFNo: SS6157ES
xperimental methodologies have become an integral part of development economist’s toolkit. Today, hundreds of RCTs are being run around the world. The advent of experimental methodologies has been particularly prominent in East Africa, where they have advanced a number of novel insights into poverty alleviation. RCTs also stress a particular vision of development, however. The greatest benefit of RCts - the use of randomization to assess the causal effects of various interventions – renders certain forms of development projects more amenable to this framework than others, for example. To date, we have very little insight into how the rise of RCTs has shifted ideas of development among local stakeholders – including government officials working on questions of development, local research communities and participants themselves. This project seeks to center the experiences of local populations to better understand how the rise of RCTs in development shapes understandings of what development is, how it is delivered and who is a deserving beneficiary.
|
USA |
2026-09-23 8:52:15 |
2029-09-23 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
JACKSON WAFULA NAMBISA
ID: UNCST-2025-R018137
|
Feasibility Study for an Inpatient Palliative Care and Hospice Facility in the Greater Kigezi Region, South-Western Uganda
REFNo: HS8389ES
General Objective
To determine whether Kabale Christian Care (KCC) should establish an inpatient palliative care and hospice facility in the greater Kigezi region and, if so, to recommend the most feasible and sustainable service delivery model, scale, location, and implementation approach.
Specific Objectives
1. To assess the burden of serious health-related suffering and the likely need for inpatient palliative and hospice care in the greater Kigezi region (in patient numbers and inpatient bed-days per year).
2. To map existing palliative care, cancer care, chronic illness care, home-based care, referral pathways, and end-of-life services across the five districts of Kabale, Kanungu, Kisoro, Rubanda, and Rukiga.
3. To identify unmet service gaps that are not adequately addressed by current outpatient, hospital-based, home-based, or outreach palliative care services.
4. To estimate the likely demand for different forms of inpatient support, including symptom-control admission, respite care, caregiver-relief admission, and end-of-life (terminal) care.
5. To assess the preferences and perceptions of patients, caregivers, clinicians, faith leaders, and community stakeholders regarding inpatient hospice and palliative care.
6. To analyse alternative service delivery models — specifically a standalone inpatient hospice and an enhanced community-based model with short-stay beds — against transparent criteria: unmet need, accessibility, clinical appropriateness, staffing feasibility, financial sustainability, cultural acceptability, and implementation risk.
7. To assess operational feasibility, including staffing, medicines (especially morphine supply), referral systems, transport, infrastructure, governance, and legal licensing requirements.
8. To assess financial feasibility, including capital expenditure (CAPEX), operating expenditure (OPEX), possible funding pathways, and sustainability scenarios (low, medium, high demand) over a five-year period.
9. To provide a clear, actionable recommendation on whether KCC should proceed, proceed in phases, or defer the proposed inpatient facility, and if proceeding, to deliver a phased implementation roadmap with costs, partners, risks, and success indicators.
|
Uganda |
2026-09-23 8:14:51 |
2029-09-23 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|